Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.

MLA

Wada, Hiroshi, et al. “Perioperative Allogenic Blood Transfusion Is a Poor Prognostic Factor after Hepatocellular Carcinoma Surgery: A Multi-Center Analysis.” Surgery Today, vol. 48, no. 1, Jan. 2018, pp. 73–79. EBSCOhost, https://doi.org/10.1007/s00595-017-1553-3.

APA

Wada, H., Eguchi, H., Nagano, H., Kubo, S., Nakai, T., Kaibori, M., Hayashi, M., Takemura, S., Tanaka, S., Nakata, Y., Matsui, K., Ishizaki, M., Hirokawa, F., Komeda, K., Uchiyama, K., Kon, M., Doki, Y., & Mori, M. (2018). Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis. Surgery Today, 48(1), 73–79. https://doi.org/10.1007/s00595-017-1553-3

Chicago

Wada, Hiroshi, Hidetoshi Eguchi, Hiroaki Nagano, Shoji Kubo, Takuya Nakai, Masaki Kaibori, Michihiro Hayashi, et al. 2018. “Perioperative Allogenic Blood Transfusion Is a Poor Prognostic Factor after Hepatocellular Carcinoma Surgery: A Multi-Center Analysis.” Surgery Today 48 (1): 73–79. doi:10.1007/s00595-017-1553-3.